$LMB

Sharp Jay sold $389K of LMB

Sharp Jay (Executive Vice President) sold 4,871 shares of Limbach Holdings, Inc. (LMB) at an average of $79.82 ($78.46–$81.32, $0.39M total) across 4 trades on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Sharp Jay
Published Jun 17, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:35 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LMB
Neutral
medium confidence
Mentioned
$LMB
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LMBNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale by an executive vice president, including trade size, price range, and confirmation of a pre-arranged 10b5-1 plan.

02

Market read

For traders, this is primarily a sentiment/positioning datapoint rather than a fundamental catalyst.

03

What to watch

The article provides only the sale details; it does not include any concurrent insider buys, changes in guidance, or operational/regulatory catalysts that would make the transaction more decision-relevant.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-17 for trades dated 2026-06-15.

Background

The article is a SEC Form 4 insider transaction disclosure for Limbach Holdings, Inc. (LMB).

Company-level read

Ticker impact

$LMBNeutralMedium confidence
Context

Limbach Holdings executive vice president Sharp Jay sold about 4,871 shares in open-market trades under a 10b5-1 plan, totaling $388,798.87.

Expected impact

Likely minimal immediate price impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction, but it explicitly states a pre-arranged 10b5-1 plan, which typically reduces interpretability versus discretionary selling.

Market effects

No clear sector read-through from a single insider sale disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, the sale can still coincide with internal views on valuation or liquidity needs, so traders may treat it as a mild caution signal.

Key entities

  • Limbach Holdings, Inc.

    US-listed company whose executive insider sale is disclosed on Form 4.

  • Sharp Jay

    Executive Vice President who sold shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LMBMed

JPMorgan downgrades Limbach stock rating on valuation concerns

JPMorgan downgraded Limbach Holdings (LMB) to Underweight, lowering its price target to $50 from $60. The stock is near its 52-week low at $42.75. Five analysts revised earnings downward. The company reported Q2 2026 earnings and revenue below expectations, with near-term margin pressures cited. Stifel lowered its price target to $86 but maintained a Buy rating.

$LMBMed

Limbach Holdings (LMB) Securities Investigation Notice

Limbach Holdings (NASDAQ: LMB) shares fell after the company cut full-year Adjusted EBITDA guidance to $78-$84 million from $90-$94 million and reported Q2 adjusted EPS of $0.64 versus about $0.93 consensus. Q2 revenue was about $173.5 million versus $177.3 million consensus. Levi & Korsinsky says it is investigating potential securities law violations.

$LMBMedAI 8/10

Why Limbach Is Buying CYMCOR For $30 Million

Limbach Holdings said it acquired CYMCOR for about $30 million to expand in data center infrastructure services. The deal, funded via cash and borrowings under its revolving credit facility, is expected to add about $12 million of professional services revenue and $4 million of adjusted EBITDA in 2027. CYMCOR manages projects with over $8 billion in budgets.

$LMBMedAI 8/10

Read Analyst Questions From Limbach’s Q2 Earnings Call

Limbach (LMB) reported Q2 revenue of $173.5M, below analysts’ $177.3M estimate, and adjusted EPS of $0.64 versus $0.93 expected. Adjusted EBITDA was $13.94M versus $19.6M expected, with operating margin at 4.3%. CEO Michael McCann cited project timing and softer healthcare and institutional demand. Full-year revenue guidance was raised to $775M midpoint, but EBITDA guidance was below estimates.

$LMBMedAI 8/10

Limbach Q2 Earnings Call Highlights

Limbach Holdings (NASDAQ: LMB) reported Q2 revenue up 35.3% to $45 million, with organic GCR revenue up 12% and acquisition-related revenue up 23.3%. Gross margin fell to 21.5% from 28%, and net income dropped 38.8% to $4.7 million. Operating cash flow rose to $18.7 million. The company raised 2026 revenue guidance to $760M-$790M and lowered adjusted EBITDA to $78M-$84M.

$LMBHighAI 9/10

Why Limbach (LMB) Stock Is Nosediving

Limbach (LMB) shares fell 31.5% after the company reported mixed Q2 2026 results and guidance below expectations. Revenue was $173.5M vs $177.3M consensus. Adjusted EPS was $0.64, 30.9% below forecasts. Full-year revenue guidance rose, but EBITDA guidance of $81M missed Wall Street.